Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) closed at $40.65 in the last session, up 5.83% from day before closing price of $38.41. In other words, the price has increased by $5.83 from its previous closing price. On the day, 0.7 million shares were traded.
Ratios:
We take a closer look at TNXP’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 11.64 and its Current Ratio is at 12.31. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On April 18, 2019, ROTH Capital Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $4.
ROTH Capital Upgraded its Neutral to Buy on August 18, 2017, while the target price for the stock was maintained at $6.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 15 ’25 when LEDERMAN SETH bought 4,000 shares for $21.55 per share. The transaction valued at 86,200 led to the insider holds 4,005 shares of the business.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 29.66 while its Price-to-Book (P/B) ratio in mrq is 1.55.
Stock Price History:
Over the past 52 weeks, TNXP has reached a high of $485.76, while it has fallen to a 52-week low of $6.76. The 50-Day Moving Average of the stock is 75.12%, while the 200-Day Moving Average is calculated to be 92.00%.
Shares Statistics:
A total of 7.32M shares are outstanding, with a floating share count of 7.32M. Insiders hold about 0.07% of the company’s shares, while institutions hold 6.61% stake in the company.
